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Highlights 
         Palliative care is an essential component of health services. It improves 
outcomes and saves cost. Despite increasing need for palliative care in all 
regions of the world, provision is woefully inadequate. 
         Despite the needs and benefits for palliative care, investment is poor even 
in high income countries. 
         Integration of palliative care, and quality of death, is greatest in high 
income countries. 
         Some low and middle income countries have shown regional leadership by 
including palliative care in the National health Plans, and by supporting policy 
to enhance provision in primary, secondary and tertiary sectors. 
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The concept and practice of palliative care  
Palliative care is defined by the World Health Organization (WHO) as "an approach 
that improves quality of life of patients and their families facing the problems 
associated with life-threatening illness, through the prevention and relief of suffering 
by means of early identification and impeccable assessment and treatment of pain 
and other problems, including physical, psychosocial, and spiritual”.1 The word 
palliative comes from the Latin palliare, meaning to cloak. The goal of palliative care 
is to ease the symptoms and other problems associated with living with an incurable 
illness, rather than to try to extend the amount of time that the patient has left to live. 
 
In this article the term palliative care will refer to care delivered by health care 
professionals working in specialist palliative care teams. Specialist palliative care 
teams are multi-professional, including doctors, nurses, social workers, and other 
allied health professionals for whom palliative care is their core daily work. Specialist 
palliative care teams deliver care directly to patients, and indirectly by supporting 
other professionals to deliver care.2 
 
The term hospice is context dependent. In the UK, hospice most often refers to an 
institution within which the health care professionals are specialists in palliative care. 
Hospices in the UK usually have inpatient beds, as well as community teams who 
see patients in their place of residence. In the United States, hospice care is the term 
used for a Medicare benefit available to people with a prognosis of six months or 
less.3 US hospice care is most often provided in the community, with inpatient units 
being less common. 
 
Since the development of the modern hospice movement by Dame Cicely Saunders 
in the UK in the 1960’s, it has become a global movement (for example the first 
hospice in Africa opened in Zimbabwe in 1979), and is often recognised as a medical 
and nursing specialty. Given the advances in the policy, practice and research of 
palliative care in the UK, in this article we will largely draw on the UK context. 
However, as an academic collaborative that has focused on palliative care as a 
global health need, we will also draw on further contexts and lessons learned from 
around the world. In 2004 the World Health Assembly passed its first resolution on 
palliative care and so now Governments have a responsibility to train health care 
professionals in palliative care, deliver appropriate and effective palliative care, and 
ensure an evidence base.   
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The benefits of palliative care 
There is now a body of evidence from controlled trials that specialist palliative care 
teams provide improved symptom control, better satisfaction with care, and improved 
quality of life for patients, and better outcomes for care-givers.4-7 Systematic reviews 
have shown that receipt of community-based palliative care is associated with double 
the odds of dying at home,8 and half the odds of cancer patients attending 
Emergency Departments in their last month of life.9 In the United States, among 
people with cancer, hospice care was associated with lower rates of hospitalization, 
intensive care unit admission, and invasive procedures close to the end-of-life.10 In 
Canada, community-based specialist palliative care is associated with reduced risk of 
acute hospital care use, and a higher rate of out-of-hospital death.11  
 
Paradoxically, although the aim of palliative care is not to lengthen life, there is early 
but growing evidence that early palliative care may also improve survival among 
people with cancer.12,13 The mechanism of this is unclear but it may be a result of 
patients receiving less chemotherapy near to the end-of-life, having fewer hospital 
admissions, or due to improvement in patients’ depression.14 In the UK, trial evidence 
has shown that a brief palliative care consultant advisory service can reduce 
symptoms and caregiver burden 15 and costs of care16. A further UK trial to integrate 
palliative care into a novel multiprofessional brief service to manage breathlessness 
found In addition to self-mastery of breathlessness, it also has a positive survival 
effect17. In an RCT evaluation from Africa, training and use of a basic assessment 
tool with a care plan in palliative care delivered by existing clinic nurses alongside 
treatment improved mental health and psychosocial problems18. 
 
 
Palliative care reduces the high costs of end-of-life care 
 
Care costs for people in the last year of life account for a large proportion of total 
health care expenditure. In the UK, around 20% of hospital bed days are related to 
the last year of life.19 In the USA, 25% of total health care expenditure is used in the 
last year of life.20 
Annual direct costs for cancer care are projected to rise in the USA from $104 billion 
in 2006 to $173 billion in 2020, driven by dramatic rises in the costs of therapy and 
the extent of care.21 These are unsustainable increases. Better integration of 
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palliative care has been suggested as a potential solution to reducing costs without 
depriving patients of benefit.21 
Evidence on the cost effectiveness of palliative care has lagged behind evidence on 
its effectiveness with respect to patient and family outcomes. This is due to the 
complexity of capturing social care and informal care costs in addition to health care 
related costs. Emerging evidence suggests that palliative care is likely to be cost-
saving overall. In a systematic review, Smith et al examined 46 studies that reported 
on costs of palliative care.22 They found a wide variety of study types, characteristics, 
and quality. Most of these studies were from the United States, and they included 
both cancer and non-cancer conditions. Despite these variations, they found a 
consistent pattern: palliative care was frequently found to be less costly than 
comparator groups, and in most cases this difference was statistically significant. 
This indicates that the expense incurred by having an extra team involved in the 
patient’s care is offset by fewer tests and treatments, and less hospital-based care.  
 
End-of-life communication 
 
It has been said that if palliative care was a drug, patients and policy makers alike 
would demand it. Unfortunately, societal attitudes towards death and dying, and a 
reluctance to speak about end-of-life care issues, mean that palliative care does not 
always seem palatable. The 2013 Neuberger review called for a National 
conversation about death and dying, to dispel some of the taboos that still surround 
it.23 Initiatives such as the Dying Matters coalition in the UK, the Death Café 
movement, and the US Conversation Project encourage the normalization of 
conversations about dying. However, many people still have a ‘not yet’ approach to 
talking about their own mortality. 
 
This is compounded by health care professionals’ reluctance to initiate conversations 
about end-of-life care preferences with their patients. A US study showed that 69% of 
patients with lung cancer (and 81% with colorectal cancer) were not aware that the 
intention of their palliative chemotherapy was not to cure their disease.24 In one 
study, around half of medical oncologists preferred not to discuss resuscitation, 
advance directives, or palliative care until there were no more treatment options 
available.25 Perhaps not surprisingly, cancer patients who have late end-of-life 
conversations are more likely to receive overly aggressive care.26 In the US, recent 
provision of reimbursement to physicians who have end-of-life conversations with 
their patients is likely to lead to such conversations becoming more mainstream. 
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Good end-of-life communication must be initiated by health care professionals, who 
in turn require adequate education and training. Remarkably, given its ubiquity, it is 
only relatively recently that caring for people who are dying has become a 
mainstream part of medical education. While palliative care is slowly gaining 
prominence on the medical curriculum, still the average time devoted to palliative 
care is 20 hours over five years.27  
 
Providing enough palliative care: a lack of investment  
 
While there is now convincing evidence that palliative care can improve patients’ 
quality of life and death, and frequently at lower costs, investment in palliative care 
services has been slow and often inadequate. In the UK, palliative care developed 
from the hospice sector, and historically much of its funding has been private or 
charitable. Currently, the charitable sector spends £950 million on hospice care 
annually, with state funding of around £460 million.28 
 
There is widespread geographical variation in investment in specialist palliative care 
services: in 2010/11 the average spend by Primary Care Trusts on specialist 
palliative care varied from £186 to £6213 per death.28 Inequalities in palliative care 
provision are widespread, with evidence of disparity according to diagnosis, age and 
relative affluence in addition to geographical location.29 
 
Improving care for people approaching the end of their lives, and providing care that 
reflects their individual choices and preferences, has been cited as a priority for the 
UK Government. The 2015 Choice review calculated that a relatively modest 
investment - £130 million – could provide a meaningful level of service improvement 
and greater choice for patients approaching the end-of-life.30 However, despite the 
government’s commitment to respond to the Choice review by the end of 2015, it is 
yet to publish its position.  
 
Global palliative care provision  
 
Access to palliative care is recognized as a human right claimable within existing 
global covenants31,32. Palliative care may be even more necessary in low and middle 
income countries where there is poorer access to health services, later presentation, 
and fewer curative treatment options.  
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In 2010, and again in 2015, the Economist Intelligence Unit attempted to rank quality 
of end-of-life care in 80 countries worldwide according to five indicators: the palliative 
and healthcare environment, human resources, the affordability of care, the quality of 
care and the level of community engagement. Not surprisingly, rich nations tend to 
rank highest in terms of quality of end-of-life care. The report showed that countries 
with a high quality of end-of-life care shared the following qualities: 
• A strong and effectively implemented national palliative care policy framework;   
• High levels of public spending on healthcare services;   
• Extensive palliative care training resources for general and specialised medical 
workers;   
• Generous subsidies to reduce the financial burden of palliative care on patients;   
• Wide availability of opioid analgesics;   
• Strong public awareness of palliative care.  
The WHO global atlas of palliative care has categorized every country according to 
the level of palliative care integration and provision33. While 74 low and middle 
income countries fall within the worst category (i.e. “no known activity”, e.g. 
Afghanistan, Bhutan, Senegal, Uzbekistan) it is notable that several African countries 
fall in the top two categories (“Preliminary integration” and “Advanced integration”, 
e.g. Kenya, Tanzania, Zambia, Zimbabwe, Uganda and South Africa).  
Sub-Saharan Africa has achieved much in advancing the policy, training, practice 
and research of palliative care. African advocacy bodies and services have worked 
hard to roll out opioid availability in districts34,35, to develop and implement simple 
outcome measures to guide and evaluate care36, and to undertake research on 
physical37, social38 spiritual39,40 and psychological aspects41 of palliative care. The 
WHO foundation measures were designed to assist countries develop a public health 
approach to cancer palliative care42: policy, education, drug availability and 
implementation. However, these foundation measures must be underpinned by local 
research that determines what the policy should advocate, how and what should be 
taught, which drugs need to be available, and how best to implement43. African has 
been an exemplar in advancing the science of palliative care, generating the original 
research urgently needed in the emerging field of global health palliative care44. The 
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African example shows how clinical cultures and public understanding can be 
changed to endure effective, compassionate and appropriate end-of-life care. Such 
change is urgently needed in many parts of the world, for example research in Cuba 
found that advanced cancer patients were often unaware of their diagnosis or 
prognosis, and that this was associated with greater distress45. 
 
Drug availability for the management of advanced cancer pain is a key challenge in 
many regions46. Very economically poor terminal cancer patients and their families in 
Bangladesh describe spending their few resources on futile treatments, yet not being 
able to access cheap and effective opioids47,48. The patchy coverage of palliative 
care highlighted in the WHO Global Atlas underlines the challenge of unequal access 
even within countries. An example of this is India, where the Kerala region has 
become well known for good availability of community-based palliative care, while 
other states have very little coverage at all49. Similar inequity exists in Africa50, and 
the challenge remains that we must expand global coverage while maintaining 
quality.  
 
Cancer palliative care policy in Africa 
According to the World Bank Cancer Mortality report of 2012 low- income countries 
largely in sub-Saharan African contributed a total of 350,000 deaths to cancer 
mortality of which 70,000 tobacco related cancers and 90,000 deaths were infection 
related cancers.  
Sub-Saharan Africa has a unique cancer picture compared to the rest of the world. It 
is the only continent where among women cervical cancer is equivalent to breast 
cancer in prevalence. According to Global Cancer Report 2014 the prevalence of 
cervical cancer among women in sub-Saharan Africa is 25.2% while breast cancer is 
25.5%. Both these are the top cancers for women while prostate and liver cancers 
are top cancers in men (World Cancer Report 2014). 
 
 The dilemma facing most cancer patients are many in Africa is lack of appropriate 
and accessible services. Most cancer patients in sub Saharan Africa either present 
late for treatment, or go to facility where appropriate cancer treatment does not 
exist. There are many cancer patients who never access any form of western 
medicine services (World Cancer Report 2014). 
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The situation is changing slowly in terms of cancer policy and cancer control plans in 
Africa. Zimbabwe and Kenya are model countries that have now adopted model 
cancer control plans that cover the whole continuum from primary prevention, early 
detection, diagnosis and treatment, support and rehabilitation as well as palliative 
care (http://www.iccp-portal.org/sites/default/files/plans) and http://www.iccp-
portal.org/cancer-plans) 
Six African countries in namely Swaziland, Mozambique, Malawi, Zimbabwe, 
Tanzania and Rwanda have national overarching standalone palliative care policies 
with clear national strategies. Uganda and Botswana have completed national 
palliative care policy documents which are awaiting approval. 
 
 
Evidence based policy 
 
As described above, an accumulation of research evidence in recent decades has 
shown that palliative care is an essential component of cancer services, improves 
outcomes for patients and their family care givers (who also have high care needs51), 
and reduces health care costs. However, further research is necessary to understand 
when the ‘right’ time to introduce palliative care is, and which models of care work 
best in different settings. Late referral is common, and this means that patients and 
their families are less able to access low cost, effective care.  
 
In order to answer these questions, investment in research is necessary. Currently in 
the UK, less than 0.5% of the cancer research budget is allocated to research that 
aims to improve end-of-life cancer care.52 In 2010 this money was allocated in 48 
separate awards, providing an average of just £25,000 per award. The danger of this 
piecemeal approach to palliative care funding is to produce a mass of small-scale 
studies that have little impact, while national policies are developed without an 
adequate evidence base.  
The importance of evidence based policy making in care of the dying is exemplified 
by the Liverpool Care Pathway.53 Developed in the late 1990s, the LCP aimed to 
improve care for people dying outside specialist palliative care settings. Greeted with 
enthusiasm by policy makers, it was rapidly rolled out nationally, and was endorsed 
in the National End-of-life Care Strategy. However, following sustained media focus 
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on its potential harms an independent review in 2013 found that there was a lack of 
convincing evidence of its benefits, and recommended that the LCP should be 
phased out.23  
 
It is essential that future policies aiming to improve care for people who are dying are 
based on appropriate evidence, and sustained investment in research is necessary 
to deliver this. 
 
 
Conclusions 
 
The nature of illness is changing. As a population, we are living longer and survival 
from disease is prolonged. This, together with a projected increase in the annual 
number of deaths,54 presents an unprecedented challenge for health care systems. 
 
While the search for a cure for cancer occupies many newspaper headlines, the fact 
that roughly 50% of people diagnosed with cancer will die from it is barely 
acknowledged. Our societal focus on cure must not come at the expense of 
openness about what to do when cure is no longer an option. When Aneurin Bevin 
founded the UK’s National Health Service in 1948, his vision was of a cradle to grave 
health service, freely available to all. However, the huge progress in maternity care in 
the intervening decades has not been matched by progress in palliative and end-of-
life care. Investment in palliative care has the potential to transform the quality of life 
and death for patients, and lead to improved outcomes in bereavement for their 
carers, while potentially avoiding burdensome (and expensive) hospital care. As the 
world’s population ages, and costs of care become an important component of health 
care planning, policy makers must turn their attention to care of the dying. The 
question is no longer why, but how, effective palliative and end-of-life care is 
provided. 
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